Stock A099430 BIO PLUS CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

All News Bio Plus Co., Ltd

Equities

A099430

KR7099430001

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-06-04 EDT 		5-day change 1st Jan Change
4,330 KRW -1.48% Intraday chart for Bio Plus Co., Ltd -8.07% -36.97%
01-24 Elevance Health Offers Stronger-Than-Expected 2024 Earnings Outlook After Fourth-Quarter Beat MT
01-24 Elevance Health Issues Upbeat 2024 Adjusted. Earnings Outlook After 4Q Revenue Gains DJ

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Elevance Health Offers Stronger-Than-Expected 2024 Earnings Outlook After Fourth-Quarter Beat
MT
Elevance Health Issues Upbeat 2024 Adjusted. Earnings Outlook After 4Q Revenue Gains
DJ
Tranche Update on BioPlus Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.
CI
Tranche Update on BioPlus Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.
CI
BioPlus Co., Ltd.'s Equity Buyback announced on May 9, 2023, has expired with 743,436 shares, representing 1.28% for ¥4,990.07 million.
CI
Elevance Health Lifts Full-Year Earnings Outlook as Third-Quarter Results Rise
MT
Elevance Health 3Q Revenue Rises on Higher Premiums
DJ
BioPlus Acquisition, Avertix Medical Terminate Business Combination Deal
MT
Tranche Update on BioPlus Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.
CI
BioPlus Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
CI
BioPlus Co., Ltd. authorizes a Buyback Plan.
CI
BioPlus Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Elevance Health to Acquire Specialty Pharmacy BioPlus for Undisclosed Sum
MT
BioPlus to Raise $14.2 Million from Share Sale; Shares Jump 4%
MT
BioPlus Co., Ltd. announced that it expects to receive KRW 19.99996275 billion in funding
CI
Tranche Update on BioPlus Co., Ltd.'s Equity Buyback Plan announced on December 7, 2021.
CI
BioPlus Co., Ltd.'s Equity Buyback announced on December 7, 2021, has expired with 199,320 shares, representing 1.43% for KRW 4,987.71 million.
CI
BioPlus Co., Ltd.'s Equity Buyback announced on October 13, 2021, has expired.
CI
BioPlus Co., Ltd.(KOSDAQ:A099430) added to S&P Global BMI Index
CI
BioPlus Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A099430 Stock
  4. News Bio Plus Co., Ltd